Privia Health Group Q2 Earnings Call Highlights

Strong Q2 performance: Privia Health’s implemented providers grew 10.1%, attributed lives increased 19.2%, and practice collections rose 12.4% to $970 million. Adjusted EBITDA climbed 29% year over year to $37.4 million. 2026 outlook raised: Management lifted guidance for attributed lives, practice collections, GAAP revenue, care margin, platform contribution and adjusted EBITDA after strong first-half execution. The company ended the quarter with more than $412 million in cash and no debt. Potential CMS changes could delay 2025 shared-savings payments by roughly 30–45 days, affecting year-end cash flow but not expected collections.

Privia Health reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from a year earlier. Management also raised its 2026 outlook for several financial measures following what Chief Executive Officer Parth Mehrotra described as strong first-half execution. The company said implemented providers increased 10.1% year over year to 5,644 as of June 30, while value-based attributed lives rose 19.2%. Total practice collections grew 12.4% to $970 million during the quarter. Adjusted EBITDA increased to $37.4 million, representing 28.3% of care margin and a 310-basis-point improvement from the prior-year period.

For the first half of 2026, practice collections increased 13.4% to $1.88 billion, care margin rose 18.3%, and adjusted EBITDA climbed 32.5% to $74.1 million, according to Chief Financial Officer David Mountcastle.

Mountcastle said Privia raised its 2026 outlook for attributed lives above the high end of its prior guidance range. The company also increased expectations to the high end of prior ranges for practice collections and GAAP revenue, and to the mid-to-high end of ranges for care margin, platform contribution and adjusted EBITDA. The company did not change its outlook for implemented providers. At the midpoint of that guidance, Privia expects to add 570 providers in 2026, or growth of 10.6% over 2025, Mehrotra said. When asked about guidance implying slower practice-collections growth in the second half, Mehrotra said the outlook reflected the company’s customary prudence rather than specific operational headwinds. He said ambulatory utilization remained favorable and noted that inpatient utilization trends reported by health systems do not directly apply to Privia’s business model.

Privia ended the quarter with more than $412 million in cash and no debt. Mountcastle said the company expects 70% to 80% of full-year adjusted EBITDA to convert to free cash flow, excluding capital deployment for business development and assuming it receives a significant portion of shared-savings cash payments for 2025 performance by year-end.

Management said proposed changes from the Centers for Medicare & Medicaid Services to the Medicare Shared Savings Program could delay final reconciliation results for the 2025 performance year until November if finalized. While Mountcastle said the development would have minimal impact on accruals, it could create an unusual year-end cash-flow dynamic depending on when CMS distributes payments and when Privia subsequently pays providers. Mehrotra said the company was not concerned about ultimately receiving the payments. He said CMS has historically delivered results in August or Septem...